| CRP |
P02741
|
C-reactive protein
|
|
3.7E-03 |
0.299 |
0.962 |
| APOE |
P02649
|
apolipoprotein E
|
|
1.9E-03 |
0.338 |
0.962 |
| NLRP3 |
Q96P20
|
NLR family pyrin domain containing 3
|
|
8.1E-04 |
0.361 |
0.962 |
| IL18 |
Q14116
|
interleukin 18
|
|
3.1E-02 |
0.365 |
0.923 |
| HLA-B |
P01889
|
major histocompatibility complex, class I, B
|
|
3.9E-05 |
0.379 |
0.885 |
| FTO |
Q9C0B1
|
FTO alpha-ketoglutarate dependent dioxygenase
|
|
8.4E-08 |
0.486 |
0.885 |
| GTF2I |
P78347
|
general transcription factor IIi
|
|
1.00 |
0.500 |
0.808 |
| TREM2 |
Q9NZC2
|
triggering receptor expressed on myeloid cells 2
|
|
3.3E-09 |
0.519 |
0.769 |
| BAZ1B |
Q9UIG0
|
bromodomain adjacent to zinc finger domain 1B
|
|
1.00 |
0.530 |
0.731 |
| DUSP1 |
P28562
|
dual specificity phosphatase 1
|
|
1.0E-02 |
0.491 |
0.808 |
| JMJD1C |
Q15652
|
jumonji domain containing 1C
|
|
1.00 |
0.517 |
0.769 |
| CETP |
P11597
|
cholesteryl ester transfer protein
|
|
1.2E-23 |
0.512 |
0.731 |
| AIM2 |
O14862
|
absent in melanoma 2
|
|
2.2E-09 |
0.521 |
0.769 |
| CYP21A2 |
P08686
|
cytochrome P450 family 21 subfamily A member 2
|
|
2.6E-04 |
0.525 |
0.769 |
| NLRC4 |
Q9NPP4
|
NLR family CARD domain containing 4
|
|
9.9E-12 |
0.556 |
0.769 |
| FADS2 |
O95864
|
fatty acid desaturase 2
|
|
1.00 |
0.575 |
0.692 |
| GCKR |
Q14397
|
glucokinase regulator
|
|
8.5E-19 |
0.604 |
0.615 |
| PTPN2 |
P17706
|
protein tyrosine phosphatase non-receptor type 2
|
|
1.00 |
0.538 |
0.692 |
| CR1 |
P17927
|
complement C3b/C4b receptor 1 (Knops blood group)
|
|
1.6E-35 |
0.533 |
0.808 |
| FADS1 |
O60427
|
fatty acid desaturase 1
|
|
0.37 |
0.582 |
0.769 |
| RGS6 |
P49758
|
regulator of G protein signaling 6
|
|
0.44 |
0.564 |
0.769 |
| ST3GAL4 |
Q11206
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 4
|
|
4.0E-02 |
0.588 |
0.692 |
| HBG2 |
P69892
|
hemoglobin subunit gamma 2
|
|
0.67 |
0.565 |
0.692 |
| NECTIN2 |
Q92692
|
nectin cell adhesion molecule 2
|
|
0.97 |
0.575 |
0.769 |
| APOC1 |
P02654
|
apolipoprotein C1
|
|
0.22 |
0.581 |
0.577 |